BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9455943)

  • 1. Cytotoxicity of cytokeratin monoclonal antibody against keratinocytes: a possible therapeutic adjunct for cholesteatoma?
    Arriaga MA; Dixon P
    Am J Otol; 1998 Jan; 19(1):26-9. PubMed ID: 9455943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New immunobiologic trends concerning etiopathogenicity of cholesteatoma].
    Bujía J
    An Otorrinolaringol Ibero Am; 1994; 21(2):199-206. PubMed ID: 7516122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the cholesteatoma microenvironment: coculture of HaCaT keratinocytes with WS1 fibroblasts induces MMP-2 activation, invasive phenotype, and proteolysis of the extracellular matrix.
    Laeeq S; Faust R
    Laryngoscope; 2007 Feb; 117(2):313-8. PubMed ID: 17204986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of endotoxin on cultured rat middle ear epithelium, rat meatal epidermis, and human keratinocytes.
    Hesseling SC; van Blitterswijk CA; Lim DJ; DeMaria TF; Bakaletz LO; Grote JJ
    Am J Otol; 1994 Nov; 15(6):762-8. PubMed ID: 8572089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of mitomycin-C-treated fibroblasts in 3-D collagen gel and conditioned medium for keratinocyte proliferation.
    Huang YC; Wang TW; Sun JS; Lin FH
    Artif Organs; 2006 Mar; 30(3):150-9. PubMed ID: 16480389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No activation of urokinase plasminogen activator by anti-desmoglein 3 monoclonal IgG antibodies in cultured human keratinocytes.
    Yamamoto Y; Aoyama Y; Shu E; Tsunoda K; Amagai M; Kitajima Y
    J Dermatol Sci; 2007 Aug; 47(2):119-25. PubMed ID: 17532189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokeratin patterns of tissues related to cholesteatoma pathogenesis.
    Van Blitterswijk CA; Grote JJ; Lutgert RW; Hesseling SC; Out CJ; Van Muijen GN; Fransen JA
    Ann Otol Rhinol Laryngol; 1989 Aug; 98(8 Pt 1):635-40. PubMed ID: 2475048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transglutaminase inhibitors induce hyperproliferation and parakeratosis in tissue-engineered skin.
    Harrison CA; Layton CM; Hau Z; Bullock AJ; Johnson TS; MacNeil S
    Br J Dermatol; 2007 Feb; 156(2):247-57. PubMed ID: 17223863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokeratin expression in cholesteatoma matrix, meatal epidermis and middle ear epithelium. A preliminary report.
    van Blitterswijk CA; Grote JJ
    Acta Otolaryngol; 1988; 105(5-6):529-32. PubMed ID: 2456666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term culture of adult murine epidermal keratinocytes.
    Yano S; Okochi H
    Br J Dermatol; 2005 Dec; 153(6):1101-4. PubMed ID: 16307643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of cell-cell adhesion enhances antibody-dependent cellular cytotoxicity: implications for antibody-based therapeutics of cancer.
    Green SK; Karlsson MC; Ravetch JV; Kerbel RS
    Cancer Res; 2002 Dec; 62(23):6891-900. PubMed ID: 12460904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunocytochemical study of cytokeratin expression in human middle ear cholesteatoma.
    Chao WY; Huang CC
    Arch Otorhinolaryngol; 1989; 246(1):37-42. PubMed ID: 2472127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the differentiated phenotype of an organotypic model of skin derived from human keratinocytes and dried porcine dermis.
    Matousková E; McKay I; Povýsil C; Königová R; Chaloupková A; Veselý P
    Folia Biol (Praha); 1998; 44(2):59-66. PubMed ID: 10730858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of interleukin (IL)-1 alpha and beta gene expression in human keratinocytes exposed to repetitive strain: their role in strain-induced keratinocyte proliferation and morphological change.
    Takei T; Kito H; Du W; Mills I; Sumpio BE
    J Cell Biochem; 1998 May; 69(2):95-103. PubMed ID: 9548558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleoplasm staining patterns and cell cycle-associated expression of Ki-67 in middle ear cholesteatoma.
    Raynov AM; Moon SK; Choung YH; Hong SP; Park K
    Am J Otolaryngol; 2005; 26(5):296-301. PubMed ID: 16137526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor/scatter factor induces VEGF in human external auditory canal cholesteatoma cell culture.
    Naim R; Sadick H; Bayerl C; Riedel F; Schafer C; Bran G; Hormann K
    Int J Mol Med; 2005 Jan; 15(1):67-71. PubMed ID: 15583829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte-colony stimulating factor enhances chimeric antibody Nd2 dependent cytotoxicity against pancreatic cancer mediated by polymorphonuclear neutrophils.
    Tamamori Y; Sawada T; Nishihara T; Yamashita Y; Ohira M; Ho JJ; Kim YS; Hirakawa-Y S Chung K
    Int J Oncol; 2002 Sep; 21(3):649-54. PubMed ID: 12168113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperproliferation-associated keratin expression in human middle ear cholesteatoma.
    Bujía J; Schilling V; Holly A; Stammberger M; Kastenbauer E
    Acta Otolaryngol; 1993 May; 113(3):364-8. PubMed ID: 7685977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engraftment of umbilical cord epithelial cells in athymic mice: in an attempt to improve reconstructed skin equivalents used as epithelial composite.
    Sanmano B; Mizoguchi M; Suga Y; Ikeda S; Ogawa H
    J Dermatol Sci; 2005 Jan; 37(1):29-39. PubMed ID: 15619432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodies.
    Iannello A; Ahmad A
    Cancer Metastasis Rev; 2005 Dec; 24(4):487-99. PubMed ID: 16408158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.